[Form 4] Corebridge Financial, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Corebridge Financial, Inc. (CRBG) Form 4 summary: The company reported a grant to Elias F. Habayeb, Chief Financial Officer, of 61,977 time-vested restricted stock units (RSUs) approved on 09/19/2025. The RSUs were granted under the 2022 Omnibus Incentive Plan and are exempt under Rule 16b-3. The award will cliff vest 100% on 09/30/2027, subject to continued employment. The Form 4 shows 284,649 shares beneficially owned following the transaction. The RSUs represent contingent rights to receive one share of common stock each and were granted at a price of $0.
Positive
- Retention-focused award: 61,977 RSUs cliff vesting on 09/30/2027 supports executive retention.
- Transparency: Form 4 discloses the transaction date (09/19/2025) and post-grant beneficial ownership (284,649 shares).
- Compliance: Grant administered under the 2022 Omnibus Incentive Plan and identified as exempt under Rule 16b-3.
Negative
- None.
Insights
TL;DR: A retention-focused RSU grant to the CFO, cliff vesting in 2027, is a routine compensation action with limited near-term market impact.
This award of 61,977 RSUs aligns executive pay with shareholder outcomes by converting future value into equity, subject to continued employment through 09/30/2027. The filing discloses 284,649 shares beneficially owned by the reporting person after the grant, which provides transparency on insider stake but does not quantify dilution or percent ownership versus outstanding shares. Because the grant is time-vested and exempt under Rule 16b-3, it is a standard retention tool rather than a performance-contingent incentive, implying compensation focus on retention rather than immediate performance acceleration.
TL;DR: The grant follows common governance practices for retention awards; cliff vesting encourages tenure but limits immediate alignment signals.
The Compensation and Management Development Committee approved the RSUs under the company’s 2022 Omnibus Incentive Plan. Cliff vesting to a single future date (09/30/2027) is a clear retention mechanism and reduces short-term selling pressure by the insider until vesting. The Form 4 properly discloses the transaction date and post-grant beneficial ownership. The filing does not indicate any performance conditions or accelerated vesting triggers, which is relevant for stakeholder assessment of pay-for-performance alignment.